NCT06616636: A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia